GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Neulasta®
pegfilgrastim is an approved drug (FDA and EMA (2002))
Compound class:
Peptide
Comment: This is a PEGylated version of recombinant human G-CSF. Pegylation increases circulating half-life. In addition to pegfilgrastim, lipegfilgrastim (Lonquex®) is a glyco-PEGylated long-acting G-CSF, that is an alternative to pegfilgrastim [1].
Biosimilars:
|
Classification ![]() |
|
| Compound class | Peptide |
| Approved drug? | Yes. EU EMA (2002) | US FDA (2002) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8114 | pegfilgrastim |
Synonyms ![]() |
| Neulasta® |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 616 |
| Other databases | |
| CAS Registry No. | 208265-92-3 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL1201568 |
| DrugBank Ligand | DB00019 |
| GtoPdb PubChem SID | 178103549 |
| Search PubMed clinical trials | pegfilgrastim |
| Search PubMed titles | pegfilgrastim |
| Search PubMed titles/abstracts | pegfilgrastim |
| Wikipedia | Pegfilgrastim |